RETRACTED ARTICLE: α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway

Abstract

BackgroundVEGF receptor 2 (VEGFR2) inhibitors, as efficient antiangiogenesis agents, have been applied in the cancer treatment. However, recently, most of these anticancer drugs have some adverse effects. Discovery of novel VEGFR2 inhibitors as anticancer drug candidates is still needed.MethodsWe used α-santalol and analyzed its inhibitory effects on human umbilical vein endothelial cells (HUVECs) and Prostate tumor cells (PC-3 or LNCaP) in vitro. Tumor xenografts in nude mice were used to examine the in vivo activity of α-santalol.Resultsα-santalol significantly inhibits HUVEC proliferation, migration, invasion, and tube formation. Western blot analysis indicated that α-santalol inhibited VEGF-induced phosphorylation of VEGFR2 kinase and the downstream protein kinases including AKT, ERK, FAK, Src, mTOR, and pS6K in HUVEC, PC-3 and LNCaP cells. α-santalol treatment inhibited ex vivo and in vivo angiogenesis as evident by rat aortic and sponge implant angiogenesis assay. α-santalol significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model. The antiangiogenic effect by CD31 immunohistochemical staining indicated that α-santalol inhibited tumorigenesis by targeting angiogenesis. Furthermore, α-santalol reduced the cell viability and induced apoptosis in PC-3 cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Molecular docking simulation indicated that α-santalol form hydrogen bonds and aromatic interactions within the ATP-binding region of the VEGFR2 kinase unit.Conclusionα-santalol inhibits angiogenesis by targeting VEGFR2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.

Monotropein promotes angiogenesis and inhibits oxidative stress‐induced autophagy in endothelial progenitor cells to accelerate wound healing

“…According to several studies, protein kinases, including AKT, mTOR, p70S6K and VEGFR‐2 kinase, can regulate angiogenesis . Here, treatment with Mtp significantly increased the phosphorylation of mTOR, p70S6K and 4EBP1, and significantly decreased the autophagy level with up‐regulated SQSTM1/p62 and down‐regulated Beclin‐1 levels.…”

Propofol promotes apoptosis and suppresses the HOTAIR-mediated mTOR/p70S6K signaling pathway in melanoma cells

“…mTOR is a multi-functional kinase associated with the regulation of important cellular processes (25). Phosphorylation of p70S6K can promote mRNA translation and the cell cycle (26). Restraining mTOR can lead to blocked p70S6K phosphorylation and translation, thereby causing cell cycle arrest and induction of apoptosis (27,28).…”

Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway

“…It has been shown that activation of Akt and ERK pathways, which can be detected by the phosphorylation of these two proteins, mediates neurogenesis in PC12 cells [17] and in human umbilical vein endothelial cells [18] . Therefore, we investigated the effects of Rd on the phosphorylation of Akt and ERK1/2.…”